Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Clinical Trials: Overview

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...

Clinical Trials

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations

Gentamicin, an aminoglycoside antibiotic, is commonly administered via intermittent intravenous infusion to treat severe infections. An intermittent one-hour infusion of gentamicin, administered at eight-hour intervals, allows for precise control of plasma drug concentrations, minimizing toxicity while ensuring therapeutic efficacy. Pharmacokinetic principles govern the dynamics of plasma concentrations and can be mathematically described using specific equations.The plasma drug concentration...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Talking to Experts: Diabetes and Frailty in Older Adults.

The journal of nutrition, health & aging..·2023

Same author

Unclassified white matter disorders: A diagnostic journey requiring close collaboration between clinical and laboratory services.

European journal of medical genetics·2022

Same author

Gait Speed and Evolution of Verbal Fluencies in Frail or Prefrail Older People with Type 2 Diabetes. A Pilot Study.

The journal of nutrition, health & aging·2021

Same author

Guidelines for the management of diabetes in care homes during the Covid-19 pandemic.

Diabetic medicine : a journal of the British Diabetic Association·2020

Same author

Revisiting the Hallmarks of Aging to Identify Markers of Biological Age.

The journal of prevention of Alzheimer's disease·2020

Same author

Sex-specific muscle and metabolic biomarkers associated with gait speed and cognitive transitions in older adults: a 9-year follow-up.

GeroScience·2020

Search research articles

Related Experiment Video

Updated: Jul 7, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

The Geriatric Minimum Data Set for clinical trials (GMDS).

G Abellan Van Kan¹, A Sinclair, S Andrieu

¹Inserum U558, Department of Geriatric Medicine, CHU Toulouse, France. abellan-van-kan-g@chu-toulouse.fr

The Journal of Nutrition, Health & Aging

|March 1, 2008

Summary

A new Geriatric Minimum Data Set (GMDS) was developed to standardize clinical research in older adults. This 25-item dataset enhances research and facilitates meta-analyses for better geriatric care.

Related Experiment Videos

Last Updated: Jul 7, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

Area of Science:

Gerontology
Clinical Research Methodology
Data Standardization

Background:

Clinical research in older adults suffers from weak evidence due to insufficient data.
Harmonization through a minimum data set is crucial for uniform nomenclature and standardized assessment tools.
A Geriatric Minimum Data Set (GMDS) was developed to address these limitations in geriatric research.

Purpose of the Study:

To develop a standardized Geriatric Minimum Data Set (GMDS) for clinical research involving older populations.
To establish a common framework for data collection in geriatric studies.
To improve the quality and comparability of research outcomes in gerontology.

Main Methods:

A network of 33 European research centers (GerontoNet) was established for collaboration.
A systematic literature review identified 79 relevant statements across functional, cognitive, nutritional, and social domains.
An expert panel evaluated and refined these statements to create the GMDS.

Main Results:

A 25-item Geriatric Minimum Data Set (GMDS) was proposed, selected from an initial 79 statements.
The GMDS encompasses 7 key domains: general information, functional performance, cognitive/emotional status, cardiovascular risk, nutritional status, biochemical parameters, and social status.
The final dataset includes specific item counts within each domain, detailing essential information for geriatric trials.

Conclusions:

The proposed GMDS offers an improved framework for geriatric research with appropriate outcome measures.
Implementation of the GMDS will significantly facilitate meta-analyses of clinical trials involving older adults.
This standardization is expected to enhance the evidence base for interventions and care in elderly populations.